Last $0.44 USD
Change Today 0.00 / 0.00%
Volume 178.7K
CMXI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lyle A. Hohnke Ph.D.

Independent Director, Cytomedix, Inc.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 5 different organizations across 11 different industries.

See Board Relationships
71$38,932

Background*

Dr. Lyle A. Hohnke, Ph.D., served as the Chief Executive Officer of Aldagen Inc., form October 15, 2010 to February 2012. Dr. Hohnke served as an Acting Chief Executive Officer at TransMolecular. Dr. Hohnke was a Partner at Tullis Dickerson & Co., Inc., which Dr. Hohnke joined in 1994 and established the southeast regional office in Birmingham, Alabama. He was a Partner at Tullis Health Investors, Tullis-Dickerson Capital Focus IV, L.P., TD Javelin Fund, L.P., TD Javelin ...

Read Full Background

Corporate Headquarters*

209 Perry Parkway
Gaithersburg, Maryland 20877

United States

Phone: 240-499-2680
Fax: 240-499-2690

Board Members Memberships*

Director
Director
Director
Former Chairman
Director
Chairman and Chief Executive Officer
1996-2004
Former Director
1996-N/A
Former Director
1998-N/A
Former Director
2006-N/A
Former Director
2008-2012
Former Chief Executive Officer and Director
2012-Present
Independent Director

Education*

MA
University of Oregon
PhD
University of Oregon
BA
Western Michigan University
MBA
Hartford Graduate Institute
Post-Doctoral Training
University of California, Los Angeles, School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$25,000
Total Calculated Compensation$38,932
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CMXI:US $0.44 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Aastrom Biosciences, Inc.
$358.3K
Matthew T. Plavan Chief Executive Officer and Director
Cesca Therapeutics Inc.
$315.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOMEDIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.